Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Press Releases

Press ReleasesSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

All Releases
View Summary Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled™ (Propylene Glycol-Free) Melphalan Meets Primary Endpoint
Apr 23, 2014
PDF 61.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Apr 21, 2014
PDF 75.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th
Mar 7, 2014
PDF 58.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results
Mar 6, 2014
PDF 115.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Fourth Quarter 2013 Financial Results Teleconference and Webcast
Feb 27, 2014
PDF 59.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Beleodaq™ (belinostat) for Injection, a novel pan-HDAC inhibitor
Feb 6, 2014
PDF 15.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 16th
Jan 9, 2014
PDF 58.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Pricing of $100 Million Convertible Notes Offering
Dec 18, 2013
PDF 14.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Offering of $100 Million of Convertible Notes
Dec 16, 2013
PDF 13.9 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights Encouraging FOLOTYN® and MARQIBO® Clinical Data Presented at the 55th Annual Meeting of the American Society of Hematology (ASH)
Dec 11, 2013
PDF 79.3 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Submission of New Drug Application for Belinostat, a novel pan-HDAC inhibitor
Dec 10, 2013
PDF 15.4 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights 13 Abstracts at the 55th Annual Meeting of the American Society of Hematology (ASH), New Orleans, Louisiana, December 7-10, 2013
Dec 6, 2013
PDF 90.7 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Financial Results for Third Quarter 2013
Nov 12, 2013
PDF 110.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the Credit Suisse 2013 Healthcare Conference in Arizona on November 13th
Nov 11, 2013
PDF 57.8 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Third Quarter 2013 Financial Results Teleconference and Webcast
Nov 8, 2013
PDF 59.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Completion of Enrollment, in Pivotal Trial of Captisol-Enabled® (Propylene Glycol-Free) Melphalan
Oct 30, 2013
PDF 61.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare Conference in New York City on September 11th
Sep 4, 2013
PDF 57.9 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Launches Marqibo® (vinCRIStine sulfate LIPOSOME injection) and Ships First Commercial Orders
Sep 3, 2013
PDF 74.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Financial Results for Second Quarter 2013
Aug 7, 2013
PDF 105.4 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Second Quarter 2013 Financial Results Teleconference and Webcast
Aug 1, 2013
PDF 58.4 KB Add to Briefcase
Showing 1-20 of 619 Page: 1 2 3 4 5 ... 31  Next 20
Add to Briefcase = add release to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
7.18
Change:
+ 0.28
Day High:
7.56
Day Low:
6.95
Volume:
3,077,600
4:00 PM ET on Apr 23, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company